Migraine Headaches
Almotriptan Malate Now Available In U.S. Pharmacies
Published in Women's Health Weekly, September 13th, 2001
Excruciating headache, nausea, light sensitivity - all symptoms of a migraine - now there's good news for the estimated 28 million people who suffer from this often disabling disease. AxertTM (almotriptan malate tablets) - a new treatment option that offers highly effective relief and has few side effects - is now available by prescription from physicians in the United States for the acute treatment of migraine with or without aura in adults.
Axert received approval from the U.S. Food and Drug Administration (FDA) in May 2001. Medication side effects pose a problem for some sufferers. In fact, a new survey commissioned by Pharmacia and conducted by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Study Concludes Estrogen Replacement Therapy Unlikely To Increase Risk - Thromboembolism
Hormone Replacement Therapy May Put Elderly Women At Risk - Alzheimer Disease
Estrogen Patch May Improve Memory For Women With AD - Diet And Nutrition
Alcohol Drinkers Consume More Calories And Cholesterol Than Nondrinkers - Disease Prevention
Flaxseed May Fight Breast Cancer In Postmenopausal Women - HIV Complications
Women At Higher Risk For Human Papillomavirus Virus Infection - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
